|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.11 USD | -0.92% |
|
+1.55% | +96.23% |
| Mar. 13 | Oppenheimer Adjusts Price Target on Corvus Pharmaceuticals to $33 From $32, Maintains Outperform Rating | MT |
| Mar. 12 | Corvus Pharmaceuticals, Inc., Q4 2025 Earnings Call, Mar 12, 2026 |
| Capitalization | 1.27B 1.08B 991M 935M 1.74B 118B 1.77B 11.63B 4.55B 56.79B 4.76B 4.66B 202B | P/E ratio 2026 * |
-21.8x | P/E ratio 2027 * | -19.5x |
|---|---|---|---|---|---|
| Enterprise value | 1.27B 1.08B 991M 935M 1.74B 118B 1.77B 11.63B 4.55B 56.79B 4.76B 4.66B 202B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 151x |
| Free-Float |
90.99% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Corvus Pharmaceuticals, Inc.
| 1 day | -0.92% | ||
| 1 week | +1.55% | ||
| Current month | +3.28% | ||
| 1 month | -1.37% | ||
| 3 months | +111.62% | ||
| 6 months | +96.49% | ||
| Current year | +96.23% |
| 1 week | 14.38 | 16.09 | |
| 1 month | 12.95 | 16.09 | |
| Current year | 6.39 | 26.95 | |
| 1 year | 3.15 | 26.95 | |
| 3 years | 0.98 | 26.95 | |
| 5 years | 0.61 | 26.95 | |
| 10 years | 0.61 | 26.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Miller
CEO | Chief Executive Officer | 74 | 2014-01-31 |
Leiv Lea
DFI | Director of Finance/CFO | 71 | 2014-10-31 |
Gabriel Luciano
COO | Chief Operating Officer | - | 2020-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Peter Thompson
BRD | Director/Board Member | 66 | 2014-10-31 |
Richard Miller
CHM | Chairman | 74 | 2014-01-26 |
Scott Morrison
BRD | Director/Board Member | 68 | 2015-11-30 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.92% | +1.55% | +366.36% | +1,352.88% | 1.27B | ||
| -0.07% | +5.53% | -1.37% | -9.49% | 47.73B | ||
| +3.21% | +2.48% | +33.96% | +21.19% | 35.48B | ||
| +1.61% | +3.22% | +19.41% | -11.11% | 29.9B | ||
| +3.76% | +57.66% | +319.99% | +588.98% | 30.23B | ||
| +1.46% | 0.00% | +31.46% | +25.47% | 28.75B | ||
| -3.25% | +3.65% | +57.04% | +197.78% | 14.93B | ||
| -1.00% | +3.22% | +3,409.12% | +3,945.87% | 14.74B | ||
| -0.28% | -0.41% | +70.01% | +169.88% | 14.81B | ||
| -0.84% | +7.59% | +36.25% | +11.97% | 14.42B | ||
| Average | +0.37% | +8.24% | +434.22% | +629.34% | 23.23B | |
| Weighted average by Cap. | +1.01% | +10.10% | +281.69% | +361.77% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 8.41M 7.12M 6.57M 6.19M 11.55M 784M 11.73M 77M 30.14M 376M 31.54M 30.88M 1.34B |
| Net income | -65.05M -55.11M -50.81M -47.92M -89.37M -6.06B -90.81M -596M -233M -2.91B -244M -239M -10.34B | -74.15M -62.82M -57.92M -54.62M -102M -6.91B -104M -679M -266M -3.32B -278M -272M -11.78B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-04-15 | 15.11 $ | -0.92% | 961,882 |
| 26-04-14 | 15.25 $ | +0.53% | 1,213,210 |
| 26-04-13 | 15.17 $ | +0.46% | 560,125 |
| 26-04-10 | 15.10 $ | -3.64% | 547,225 |
| 26-04-09 | 15.67 $ | +5.31% | 677,258 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CRVS Stock
Select your edition
All financial news and data tailored to specific country editions

















